ABBVIE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 163.8 USD | +1.85% |
|
+2.61% | +5.69% |
| 04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
| 04-29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 290B | ||||||
| 546B | ||||||
| 359B | ||||||
| 323B | ||||||
| 234B | ||||||
| 198B |
- Stock Market
- Equities
- ABBV Stock
- Charts AbbVie Inc.
- Sector Chart
